| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $135.7M | +8.9% | +17.1% |
| Cost of Revenue | $100.1M | +6.1% | +13.9% |
| Gross Profit | $35.6M | +17.3% | +27.3% |
| R&D Expense | $2.4M | -0.9% | -15.9% |
| SG&A Expense | $15.5M | +15.0% | +19.1% |
| Operating Income | $6.7M | +63.1% | +62.7% |
| Pre-tax Income | $5.4M | +78.6% | +123.6% |
| Income Tax | $1.6M | +48.4% | +118.9% |
| Net Income | $3.8M | +95.8% | +125.7% |
| EPS (Basic) | $0.08 | +100.0% | +100.0% |
| EPS (Diluted) | $0.08 | +100.0% | +100.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.4M | -17.9% | -31.0% |
| Accounts Receivable | $50.8M | +10.9% | -11.5% |
| Current Assets | $261.5M | -2.6% | -12.4% |
| Total Assets | $538.0M | -1.9% | -7.1% |
| Current Liabilities | $58.1M | +7.9% | -9.1% |
| Total Liabilities | $174.6M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $39.6M | — | — |
| Capital Expenditures | $18.9M | — | — |
| Investing Cash Flow | -$23.5M | — | — |
| Financing Cash Flow | -$22.9M | — | — |
| Free Cash Flow | $20.7M | — | — |
| -18.7% |
| Stockholders' Equity | $363.4M | +0.1% | -0.2% |